Table 1 Association of miR-138-5p expression with clinicopathologic characteristics of prostate cancer
From: miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
Parameters | Number of cases | miR-138-5p expression | p-value | |
|---|---|---|---|---|
High (%) | Low (%) | |||
Age (years) | 0.830 | |||
 < 60 | 24 | 14 | 10 |  |
 ≥ 60 | 36 | 22 | 14 |  |
Tumor size | 0.526 | |||
 < 4 cm | 28 | 18 | 10 |  |
 ≥ 4 cm | 32 | 18 | 14 |  |
Gleason score | 0.025 | |||
 ≤ 7 | 40 | 28 | 12 |  |
 > 7 | 20 | 8 | 12 |  |
Lymph node metastasis | 0.009 | |||
 No | 37 | 27 | 10 |  |
 Yes | 23 | 9 | 14 |  |
Bone metastasis | 0.109 | |||
 No | 35 | 24 | 11 |  |
 Yes | 25 | 12 | 13 |  |